SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-039784
Filing Date
2019-11-04
Accepted
2019-11-04 16:07:25
Documents
57
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tptx-10q_20190930.htm 10-Q 2207851
2 EX-10.3 tptx-ex103_30.htm EX-10.3 48028
3 EX-31.1 tptx-ex311_8.htm EX-31.1 20971
4 EX-31.2 tptx-ex312_9.htm EX-31.2 19843
5 EX-32.1 tptx-ex321_6.htm EX-32.1 9564
6 EX-32.2 tptx-ex322_7.htm EX-32.2 10159
  Complete submission text file 0001564590-19-039784.txt   5927369

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tptx-20190930.xml EX-101.INS 1084559
8 XBRL TAXONOMY EXTENSION SCHEMA tptx-20190930.xsd EX-101.SCH 36862
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tptx-20190930_cal.xml EX-101.CAL 39228
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tptx-20190930_def.xml EX-101.DEF 94861
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tptx-20190930_lab.xml EX-101.LAB 309012
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tptx-20190930_pre.xml EX-101.PRE 222238
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38871 | Film No.: 191189822
SIC: 2834 Pharmaceutical Preparations